SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
JPT Peptide Technologies GmbH, IUCT and LEITAT Announce Collaboration on the Development of Novel Biofocused Anticancer Therapies (NOBITAN)